Artículos del autor

solaci

Day 4

AVOID: Randomized controlled trial of oxygen therapy in AMI with ST-segment elevation: Air versus oxygen in myocardial infarction

Dion Stub2014-11-20
solaci -
Day 4

LIFELINE STEMI ACCELERATOR TRIAL: Improving the duration of treatment of AMI can save even more lives

Matthew W Sherwood2014-11-20
solaci -
Day 1

PARTNER to 5 years. TAVR is an effective alternative to surgery in high risk patients

This study included 699 patients with severe aortic stenosis and high surgical risk of whom 348 received...
solaci -
Day 1

PEGASUS-TIMI 54: Ticagrelor plus ASA in stable patients

This double-blind study included 21162 patients with a history of acute myocardial infarction randomized to ticagrelor 90...
solaci -
Day 1

Reduction of ischemic events after 30 months of prasugrel following TAXUS stent implantation

Article The TAXUS Liberté Post Approval study included patients treated with TAXUS paclitaxel DES receiving prasugrel for 12...
solaci -
Day 1

ISAR-SAFE: 6 vs. 12 month clopidogrel administration after DES implantation

The aim of this randomized double blind control trial was to validate the safety and efficacy of...
solaci -
Day 1

DAPT TRIAL: double antiaggregation remains controversial

Article This multicenter randomized control study with placebo was designed to determine the risks and benefits of double...
solaci -
Day 1

ITALIC PLUS: 6 months of double antiaggregation for no less than 24 months

Article This multicenter study included patients receiving the second generation stent XIENCE V (Abbott Vascular) randomized to 6...
solaci -